{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:02:57Z","timestamp":1767848577849,"version":"3.49.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neuropharm.2020.108009","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T02:16:58Z","timestamp":1581646618000},"page":"108009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration"],"prefix":"10.1016","volume":"168","author":[{"given":"Noelle C.","family":"Anastasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis J.","family":"Sholler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja J.","family":"Stutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina R.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Bjork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108009_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2008.10.010","article-title":"Current status of inverse agonism at serotonin(2A) (5-HT(2A)) and 5-HT(2C) receptors","volume":"121","author":"Aloyo","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108009_bib2","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1038\/tp.2013.131","article-title":"Variation within the serotonin (5-HT) 5-HT(2)C receptor system aligns with vulnerability to cocaine cue reactivity","volume":"4","author":"Anastasio","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108009_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/acschemneuro.5b00094","article-title":"Serotonin (5-HT) 5-HT2A receptor (5-HT2AR):5-HT2CR imbalance in medial prefrontal cortex associates with motor impulsivity","volume":"6","author":"Anastasio","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/npp.2013.199","article-title":"Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence","volume":"39","author":"Anastasio","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/npp.2016.259","article-title":"Repeated 7-day treatment with the 5-HT2C agonist lorcaserin or the 5-HT2A antagonist pimavanserin alone or in combination fails to reduce cocaine vs food choice in male rhesus monkeys","volume":"42","author":"Banks","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib6","doi-asserted-by":"crossref","first-page":"846589","DOI":"10.1155\/2015\/846589","article-title":"Genotype-Dependent difference in 5-HT2C receptor-induced hypolocomotion: comparison with 5-HT2A receptor functional activity","volume":"2015","author":"Bazovkina","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2020.108009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.04.035","article-title":"(1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist\/antagonist activity","volume":"615","author":"Booth","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1060028017693029","article-title":"Pimavanserin: a novel antipsychotic for Parkinson's disease psychosis","volume":"51","author":"Bozymski","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2020.108009_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108009_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-007-0916-7","article-title":"Stimulation of serotonin(2C) receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats","volume":"196","author":"Burbassi","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.npp.1300346","article-title":"Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Burmeister","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbr.2012.11.030","article-title":"Antagonizing 5-HT(2)A receptors with M100907 and stimulating 5-HT(2)C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats","volume":"240","author":"Burton","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108009_bib13","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health","author":"Center for Behavioral Health Statistics and Quality","year":"2018"},{"key":"10.1016\/j.neuropharm.2020.108009_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/acschemneuro.6b00439","article-title":"Synthesis and structure-activity relationships of tool compounds based on WAY163909, a 5-HT2C receptor agonist","volume":"8","author":"Chen","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/pha0000209","article-title":"Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys","volume":"26","author":"Collins","year":"2018","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108009_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.115.228833","article-title":"Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys","volume":"356","author":"Collins","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2013.06.030","article-title":"Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction","volume":"76 Pt B","author":"Cunningham","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/cn300072u","article-title":"Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction","volume":"4","author":"Cunningham","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2011.04.034","article-title":"Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues","volume":"61","author":"Cunningham","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-004-2010-8","article-title":"Risperidone diminishes cocaine-induced craving","volume":"178","author":"De La Garza","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0376-8716(96)01278-1","article-title":"Failure of ritanserin to block cocaine cue reactivity in humans","volume":"42","author":"Ehrman","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108009_bib22","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","article-title":"Psychomotor stimulant addiction: a neural systems perspective","volume":"22","author":"Everitt","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib23","first-page":"35","article-title":"Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats","volume":"57","author":"Filip","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2020.108009_bib24","first-page":"576","article-title":"Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.npp.1301509","article-title":"The 5-HT(2C) receptor agonist RO 60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine and contextual cues","volume":"33","author":"Fletcher","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.116.236307","article-title":"Effects of lorcaserin on cocaine and methamphetamine self-administration and reinstatement of responding previously maintained by cocaine in rhesus monkeys","volume":"359","author":"Gerak","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1037\/pha0000234","article-title":"Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys","volume":"27","author":"Gerak","year":"2019","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108009_bib28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.bmcl.2018.02.058","article-title":"Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907","volume":"28","author":"Gilbertson","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2020.108009_bib29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-3565(24)39021-4","article-title":"Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior","volume":"295","author":"Grottick","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib30","first-page":"525","article-title":"Lorcaserin (Belviq): a selective serotonin 5-HT2C agonist in the treatment of obesity","volume":"38","author":"Gustafson","year":"2013","journal-title":"P T"},{"key":"10.1016\/j.neuropharm.2020.108009_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2015.09.028","article-title":"The 5-HT2C receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity","volume":"101","author":"Harvey-Lewis","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107417","article-title":"Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential","volume":"205","author":"Higgins","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108009_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.6b00444","article-title":"Studies to examine potential tolerability differences between the 5-HT2C receptor selective agonists lorcaserin and CP-809101","volume":"8","author":"Higgins","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/npp.2011.303","article-title":"The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control","volume":"37","author":"Higgins","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108009_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/FBP.0b013e3283656db6","article-title":"Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios","volume":"24","author":"Hubbard","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib38","article-title":"State estimates of past year cocaine use among young adults: 2014 and 2015","author":"Hughes","year":"2016","journal-title":"Cent. Behav. Health. Qual. Rep."},{"key":"10.1016\/j.neuropharm.2020.108009_bib39","first-page":"CD006306","article-title":"Antipsychotic medications for cocaine dependence","volume":"3","author":"Indave","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2020.108009_bib40","series-title":"Design and Analysis: A Researcher's Handbook","author":"Keppel","year":"1973"},{"key":"10.1016\/j.neuropharm.2020.108009_bib41","series-title":"The Neuroscience of Cocaine : Mechanisms and Treatment","first-page":"627","article-title":"Medication strategies for the management of cocaine use disorder","author":"Kohut","year":"2017"},{"key":"10.1016\/j.neuropharm.2020.108009_bib42","first-page":"760","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2020.108009_bib43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1037\/0735-7044.115.5.1086","article-title":"Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine","volume":"115","author":"Kruzich","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0091-3057(93)90295-5","article-title":"MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine","volume":"44","author":"Lacosta","year":"1993","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108009_bib45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/jpet.111.183525","article-title":"Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats","volume":"338","author":"Levin","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.addbeh.2011.10.003","article-title":"Increased intra-individual reaction time variability in cocaine-dependent subjects: role of cocaine-related cues","volume":"37","author":"Liu","year":"2012","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2020.108009_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4088\/JCP.v69n0321","article-title":"A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men","volume":"69","author":"Loebl","year":"2008","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108009_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(98)00139-5","article-title":"The spectrum of behaviors influenced by serotonin","volume":"44","author":"Lucki","year":"1998","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108009_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/jpet.111.186981","article-title":"Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys","volume":"341","author":"Manvich","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent increases in cocaine-related overdose deaths and the role of opioids","volume":"107","author":"McCall Jones","year":"2017","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.neuropharm.2020.108009_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FBP.0b013e32834aff98","article-title":"Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease","volume":"22","author":"McFarland","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003352.pub4","article-title":"Dopamine agonists for the treatment of cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2020.108009_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2020.108009_bib54","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1074\/jbc.M117.779041","article-title":"Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers","volume":"292","author":"Moutkine","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108009_bib55","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1523\/JNEUROSCI.1437-13.2013","article-title":"Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates","volume":"33","author":"Murnane","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/acschemneuro.6b00413","article-title":"Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats","volume":"8","author":"Neelakantan","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/FBP.0b013e3282f1c94b","article-title":"Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats","volume":"18","author":"Neisewander","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(01)00255-4","article-title":"Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine","volume":"102","author":"Newton","year":"2001","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108009_bib59","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1037\/a0014592","article-title":"Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model","volume":"123","author":"Nic Dhonnchadha","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02244643","article-title":"Effects of serotonergic manipulations on cocaine self-administration in rats","volume":"110","author":"Peltier","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/syn.21592","article-title":"5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen","volume":"66","author":"Pockros","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.108009_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-010-2071-9","article-title":"Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats","volume":"213","author":"Pockros","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108009_bib63","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fphar.2018.01424","article-title":"Pimavanserin and lorcaserin attenuate measures of binge eating in male Sprague-Dawley rats","volume":"9","author":"Price","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.psych.54.101601.145237","article-title":"Addiction","volume":"54","author":"Robinson","year":"2003","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib65","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pbb.2008.07.004","article-title":"Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice","volume":"91","author":"Rowland","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108009_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17460441.2018.1394838","article-title":"Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis","volume":"13","author":"Sahli","year":"2018","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108009_bib68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(00)00377-4","article-title":"Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats","volume":"67","author":"Schenk","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108009_bib69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/cn200077q","article-title":"Synthesis and evaluation of dimeric derivatives of 5-HT(2A) receptor (5-HT(2A)R) antagonist M-100907","volume":"2","author":"Shashack","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/jpet.118.251199","article-title":"The 5-HT2A receptor (5-HT2AR) regulates impulsive action and cocaine cue reactivity in male Sprague-Dawley Rats","volume":"368","author":"Sholler","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/jm0709034","article-title":"Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity","volume":"51","author":"Smith","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108009_bib72","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/acschemneuro.7b00309","article-title":"Novel bivalent 5-HT2A receptor antagonists exhibit high affinity and potency in vitro and efficacy in vivo","volume":"9","author":"Soto","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108009_bib73","series-title":"Reconciling the Role of Central Serotonin Neurons in Human and Animal Behavior","first-page":"319","author":"Soubri\u00e9","year":"1986"},{"key":"10.1016\/j.neuropharm.2020.108009_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/026988118800200201","article-title":"Interactions of antidepressants and ethanol on spontaneous locomotor activity and rotarod performance in NMRI and C57BL\/6 mice","volume":"2","author":"Stromberg","year":"1988","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2016.02.052","article-title":"Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system","volume":"324","author":"Swinford-Jackson","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108009_bib76","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization","volume":"325","author":"Thomsen","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108009_bib77","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pbb.2008.04.010","article-title":"A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model","volume":"90","author":"Vanover","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108009_bib78","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0091270007299431","article-title":"Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers","volume":"47","author":"Vanover","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108009_bib79","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/jpet.105.097006","article-title":"Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropylo xy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist","volume":"317","author":"Vanover","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:02:28Z","timestamp":1758438148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":78,"alternative-id":["S0028390820300757"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108009"}}